Kyle Moran - 25 Sep 2024 Form 4 Insider Report for Wave Life Sciences Ltd. (WVE)

Signature
/s/ Kyle Moran
Issuer symbol
WVE
Transactions as of
25 Sep 2024
Transactions value $
-$154,314
Form type
4
Filing time
27 Sep 2024, 20:00:03
Previous filing
05 Apr 2024
Next filing
11 Oct 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WVE Ordinary Shares Sale -$154K -17.1K -46.44% $9.00 19.8K 25 Sep 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2023.
F2 Includes 3,002 ordinary shares acquired on July 14, 2024, under the issuer's 2019 Employee Share Purchase Plan.